Literature DB >> 8918698

IL-4 production by allergen-stimulated primary cultures: identification of basophils as the major IL-4-producing cell type.

M T Kasaian1, M J Clay, M P Happ, R D Garman, S Hirani, M Luqman.   

Abstract

As a potent inducing agent for IgE production and differentiation factor for allergen-specific Th2 cells, IL-4 is a key regulatory cytokine both in the pathogenesis of allergic disease and in the ongoing allergic response. The assay of in vitro IL-4 production has often been used to compare the allergen responses of T cells isolated from atopic and non-atopic subjects. Because peripheral blood basophils also have the capacity to respond to specific allergen by producing IL-4, we investigated the relative contribution of these two cell types to IL-4 production in allergen-stimulated primary cultures. Among unfractionated peripheral blood mononuclear cells (PBMC), the major producers of detectable IL-4 in primary in vitro cultures were found to be basophils based on: (i) an allergen dose-response corresponding closely to that required for basophil histamine release and lower than that required for T cell activation; (ii) a rapid time course for IL-4 production (detectable at 3 h), inconsistent with the typical activation requirements of fresh T cells; (iii) the production of comparable levels of IL-4 in cultures stimulated with allergen or anti-IgE; and (iv) the complete loss of detectable IL-4 production following specific depletion of basophils from PBMC. The T cells in these cultures were functionally able to produce IL-4, as demonstrated by mitogen activation of basophil-depleted PBMC. These findings demonstrate that although IL-4 production in primary in vitro cultures can be used as a sensitive indicator of allergen responsiveness, the accurate interpretation of this result requires identification of the responding cell type. Furthermore, these findings raise the possibility that basophil production of IL-4 early in the course of allergen stimulation may shape subsequent T cell responses both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918698     DOI: 10.1093/intimm/8.8.1287

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 2.  IgE and FcepsilonRI regulation.

Authors:  Donald MacGlashan
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

3.  IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.

Authors:  Matthew R Silver; Alexander Margulis; Nancy Wood; Samuel J Goldman; Marion Kasaian; Divya Chaudhary
Journal:  Inflamm Res       Date:  2009-09-18       Impact factor: 4.575

4.  The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives.

Authors:  Radhia Boumiza; Anne-Lise Debard; Guillaume Monneret
Journal:  Clin Mol Allergy       Date:  2005-06-30

5.  Role of basophils in the pathogenesis of minimal change nephrotic syndrome: A literature review.

Authors:  Qingjun Pan; Jing Wu; Jingli Tao; Yanwen Chen; Lu Li; Zhenzhen Deng; Weijing Liu; Huafeng Liu
Journal:  Exp Ther Med       Date:  2014-08-12       Impact factor: 2.447

6.  Schistosoma mansoni Egg-Released IPSE/alpha-1 Dampens Inflammatory Cytokine Responses via Basophil Interleukin (IL)-4 and IL-13.

Authors:  Katrin Knuhr; Kristina Langhans; Sandra Nyenhuis; Kerstin Viertmann; Anna M Overgaard Kildemoes; Michael J Doenhoff; Helmut Haas; Gabriele Schramm
Journal:  Front Immunol       Date:  2018-10-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.